Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of chronic diseases across the globe
3.2.1.2 Technological advancements in transplant boxes
3.2.1.3 Growing awareness regarding organ transplantation
3.2.1.4 Increasing geriatric population base
3.2.2 Industry pitfalls & challenges
3.2.2.1 Dearth of organ donors
3.2.2.2 Stringent regulatory framework
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Kidney
5.3 Liver
5.4 Heart
5.5 Lung
5.6 Other applications
Chapter 6 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Hospitals
6.3 Transplant centers
6.4 Other end-users
Chapter 7 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Accord Healthcare Ltd.
8.2 BioLife Solutions Inc.
8.3 BioSpherix Ltd.
8.4 Dr. Franz Koehler Chemie GmbH
8.5 Medtronic plc
8.6 OrganOx Limited
8.7 Organ Recovery Systems
8.8 Paragonix Technologies, Inc.
8.9 Preservation Solution Inc.
8.10 Shanghai Genext Medical Technology Co. Ltd.
8.11 Thermo Fisher Scientific Inc.
8.12 ThermoGenesis Holdings Inc.
8.13 TransMedics Inc.
8.14 Transplant Systems Pty. Ltd.
8.15 XVIVO Perfusion AB
